These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36383070)
1. Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease. Pacheco CS; Brooks RM; White KM Mil Med; 2023 Jul; 188(7-8):e2826-e2828. PubMed ID: 36383070 [TBL] [Abstract][Full Text] [Related]
2. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease. Walters KM; Waldram JD; Woessner KM; White AA Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983 [TBL] [Abstract][Full Text] [Related]
3. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195 [TBL] [Abstract][Full Text] [Related]
4. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?]. Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556 [TBL] [Abstract][Full Text] [Related]
5. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study. Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986 [TBL] [Abstract][Full Text] [Related]
6. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD). Simon RA; Dazy KM; Waldram JD Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486 [TBL] [Abstract][Full Text] [Related]
7. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review. Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. Rajan JP; Wineinger NE; Stevenson DD; White AA J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015 [TBL] [Abstract][Full Text] [Related]
9. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD). Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997 [TBL] [Abstract][Full Text] [Related]
10. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold? O'Brien EK; Jerschow E; Divekar RD Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory treatments for aspirin exacerbated respiratory disease. Moebus RG; Han JK Am J Rhinol Allergy; 2012; 26(2):134-40. PubMed ID: 22487291 [TBL] [Abstract][Full Text] [Related]
12. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data. Adame MJ; Raji M; Shan Y; Zhang Y; Kuo YF; Tripple JW J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3445-3453.e6. PubMed ID: 37468040 [TBL] [Abstract][Full Text] [Related]
13. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data. San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881 [TBL] [Abstract][Full Text] [Related]
14. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases]. Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764 [TBL] [Abstract][Full Text] [Related]
15. Current complications and treatment of aspirin-exacerbated respiratory disease. Cook KA; Stevenson DD Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219 [TBL] [Abstract][Full Text] [Related]
16. Aspirin-exacerbated respiratory disease and current treatment modalities. Sakalar EG; Muluk NB; Kar M; Cingi C Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156 [TBL] [Abstract][Full Text] [Related]
18. Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose. Laidlaw TM; Chu DK; Stevens WW; White AA J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1462-1467. PubMed ID: 34999274 [TBL] [Abstract][Full Text] [Related]
20. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology. Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]